EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
3.4.23.B17 | VAQNYPIVQ + H2O |
Ala and Pro are preferred at position P4 |
walleye dermal sarcoma virus |
VAQNY + PIVQ |
- |
? |
3.4.23.B17 | VPQNYPIVQ + H2O |
Ala and Pro are preferred at position P4 |
walleye dermal sarcoma virus |
VPQNY + PIVQ |
- |
? |
3.4.23.B17 | VSGNYPIVQ + H2O |
Gly is preferred at position P3 |
walleye dermal sarcoma virus |
VSGNY + PIVQ |
- |
? |
3.4.23.B17 | VSQAYPIVG + H2O |
peptides with an Asn, Cys or Leu at position P2 are the best substrate, lower activity with Ala or Ile at position P2, no activity with Gly |
walleye dermal sarcoma virus |
VSQAY + PIVG |
- |
? |
3.4.23.B17 | VSQCYPIVG + H2O |
peptides with an Asn, Cys or Leu at position P2 are the best substrate, lower activity with Ala or Ile at position P2, no activity with Gly |
walleye dermal sarcoma virus |
VSQCY + PIVG |
- |
? |
3.4.23.B17 | VSQIYPIVG + H2O |
peptides with an Asn, Cys or Leu at position P2 are the best substrate, lower activity with Ala or Ile at position P2, no activity with Gly |
walleye dermal sarcoma virus |
VSQIY + PIVG |
- |
? |
3.4.23.B17 | VSQLYPIVG + H2O |
peptides with an Asn, Cys or Leu at position P2 are the best substrate, lower activity with Ala or Ile at position P2, no activity with Gly |
walleye dermal sarcoma virus |
VSQLY + PIVG |
- |
? |
3.4.23.B17 | VSQNAPIVQ + H2O |
Phe, Tyr, Leu or Met, Ala in order of decreasing efficiency, at position P1 |
walleye dermal sarcoma virus |
VSQNA + PIVQ |
- |
? |
3.4.23.B17 | VSQNFPIVQ + H2O |
Phe, Tyr, Leu or Met, Ala in order of decreasing efficiency, at position P1 |
walleye dermal sarcoma virus |
VSQNF + PIVQ |
- |
? |
3.4.23.B17 | VSQNLPIVQ + H2O |
Phe, Tyr, Leu or Met, Ala in order of decreasing efficiency, at position P1 |
walleye dermal sarcoma virus |
VSQNL + PIVQ |
- |
? |